Pharos replaces manual pharmacovigilance with AI agents that process cases, detect signals, and file regulatory submissions around the clock.
Adverse event reports are growing exponentially. Regulatory deadlines don't move. Qualified PV professionals are scarce and expensive. The industry spends over $10 billion a year on safety operations that are still largely manual.
End-to-end pharmacovigilance, run by AI agents
Ingests adverse event reports from any source: emails, call transcripts, literature, social media, partner submissions. Extracts structured data, codes to MedDRA, and populates your safety database without human touch.
Continuously monitors your case data for emerging safety signals using statistical and AI methods. No more quarterly batch analysis. Surfaces risks the moment patterns emerge.
Auto-generates E2B(R3) ICSRs, PSURs, and aggregate reports. Validates against FDA, EMA, and PMDA requirements before submission. Meets every deadline without manual chasing.
Enterprise PV platforms cost $500K+ and take a year to implement. Pharos is self-serve, affordable, and live in days. Built for the teams that need AI most but can't afford Oracle.
Every adverse event deserves the same rigor whether it's the 10th report or the 10,000th. Pharos makes that possible by removing the bottleneck between data and action.